Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Description, Course and Treatment of Immune Checkpoint Inhibitor-induced Hepatitis

NCT06864481 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT06864481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06864481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Description, Course and Treatment of Immune Checkpoint Inhibitor-induced Hepatitis
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Recruiting
Start date
April 22, 2025
Completion date
April 22, 2028
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer patients, liver injury, secondary to immune checkpoint inhibitors